Meliha D

Meliha D. currently serves as a Medical Advisor at Chiesi Nederland, where she plays a pivotal role in advancing the company’s initiatives within the Rare Diseases, Endocrinology, and Metabolism sectors. Her responsibilities encompass providing strategic medical insights, supporting the development and implementation of innovative treatment protocols, and fostering strong collaborations with key opinion leaders (KOLs) across these specialized fields. Meliha’s expertise in KOL management and identification enables her to build meaningful relationships with leading clinicians and researchers, facilitating the exchange of cutting-edge scientific knowledge and ensuring that Chiesi’s therapeutic approaches align with the latest clinical evidence.

In her role, Meliha is actively involved in project management activities, overseeing the planning and execution of clinical and educational initiatives aimed at improving patient outcomes. Her background in drug discovery, pharmaceutical chemistry, and cancer research equips her with a comprehensive understanding of the drug development process, which she leverages to support the company’s pipeline and strategic goals. She also contributes to the design and dissemination of scientific presentations, ensuring that complex data is communicated effectively to diverse audiences.

Driven by her passion to positively impact people's lives, Meliha continuously seeks opportunities to expand her expertise in pulmonology and rare diseases, aligning her work with her broader mission to provide the best possible care for patients. Her dynamic approach, combined with her skills in project management and KOL engagement, positions her as a valuable asset within Chiesi Nederland’s medical affairs team, dedicated to advancing innovative therapies and improving healthcare outcomes on a global scale.